Astrocyte activation observed in the MPTP mouse model and Parkinson's disease patients participates in the cascade of deleterious events that ultimately leads to death of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The present study aimed to elucidate whether inhibiting astrocyte activation was involved in the protective effects of iptakalim (Ipt) 
Introduction
Astrocytes, the major population in the brain, play a crucial role in maintaining normal brain physiology during development and in adulthood (Volterra and Meldolesi, 2005) . Increasing evidence has demonstrated that astrocyte activation was involved in the pathogenesis of many neurodegenerative disorders, such as Parkinson's disease (PD) (Marchetti and Abbracchio, 2005 ; Teismann et al., 2003) . Indeed, activated astrocytes produce a number of neurotoxic molecules, including pro-inflammatory factors, reactive oxygen species and reactive nitrogen species (Aschner, 1998 ; Lau and Yu, 2001 ). These factor-mediated inflammatory processes contribute to neurodegenerative disorders (Ikeda and Murase, 2004 ; Minghetti, 2005) . Thus, the drugs that can inhibit astrocyte activation and subsequent inflammatory processes may provide therapeutic benefits for neurodegenerative disorders such as PD (Seifert et al., 2006) . ATP-sensitive potassium (K ATP ) channels, which link cell metabolism to its membrane potential, belong to a class of inwardly rectifying potassium channels that are widely distributed in the brain and localized in the basal ganglia with higher levels (Dunn-Meynell et al., 1998) . Emerging evidence, including from our laboratory, has revealed a novel neuronal protective role of opening K ATP channels in PD models both in vivo and in vitro (Tai et al., 2003 ; Wang et al., 2005 ; Yang et al., 2004 Yang et al., , 2006a . Since most developed K ATP channel openers fail to pass through the blood-brain barrier, there are few effective K ATP channel openers to be used in vivo to investigate the role of K ATP channels in neurodegenerative disorders. Therefore, novel K ATP channel openers, which can permeate the blood-brain barrier and have low toxic side-effects, are considered as potential neuroprotectants (Wang et al., 2006 ; Yang et al., 2005) .
Iptakalim (Ipt), a lipophilic para-amino compound with low molecular weight, can freely cross the blood-brain barrier and has been demonstrated to be a novel K ATP channel opener by pharmacological, electrophysiological, biochemical studies, and receptor binding tests (Wang, 2003 ; Wang et al., 2004 ; Xie et al., 2005) . Ipt was initially designed and synthesized as a novel antihypertensive drug (Wang, 1998) . Based on the technical requirement for novel antihypertensive drug approval, the pre-clinical investigation of Ipt has been completed and clinical trials are currently underway (Wang, 2003) . Furthermore, our previous studies provided compelling support for the neuroprotective effects of Ipt on behavioural recovery and neuronal survival in various animal models, such as stroke and PD, at doses not affecting normal blood pressure Yang et al., 2004 Yang et al., , 2005 . However, the mechanism involved in the protective effect of Ipt requires further study.
1-methyl-4-phenylpyridinium ion (MPP + ), a metabolite of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) in astrocytes, blocks mitochondrial complex I and finally triggers selective dopaminergic degeneration, which is similar to the pathology found in PD (Tipton and Singer, 1993) . Interestingly, a recent study demonstrated that an increase in the number of GFAPimmunopositive astrocytes was also found in the striatum and substantia nigra of MPTP-treated mice, suggesting that reactive astrocytes may play a key role in the regions damaged by MPTP (Smeyne et al., 2005 ; Vila et al., 2001) . Thus, the drugs that can regulate astrocyte activation may exert neuroprotective effect against the toxicity of MPTP/MPP + . Mitochondrial complex I inhibitors, such as rotenone and MPP + , result in astrocyte-and microglia-mediated neuroinflammation and K ATP channels are considered as potential downstream targets of mitochondrial complex I inhibition (Liss et al., 2005) . p38 MAPK protein, as a targeted signalling molecule in neurodegeneration, can be phosphorylated to initiate a signal cascade that regulates synthesis of a variety of proinflammatory factors, such as TNF-a (Kumar et al., 2003 ; Saklatvala, 2004) . We recently reported that Ipt could alleviate rotenone-induced degeneration of dopaminergic neurons by inhibiting p38 MAPKmediated microglia activation . In the present study, our main aim was to investigate whether Ipt could inhibit MPP + -induced astrocyte activation via regulating p38 MAPK signalling transduction and thus prevent degeneration of dopaminergic neurons.
Methods

Animals and reagents
A total of 75 adult male Sprague-Dawley rats, weighing 200-250 g at the start of the experimental procedure, were used. All animals were housed in groups of five per cage under standard laboratory conditions with free access to food and water, constant room temperature of 22 xC, 50-60 % humidity, and a 12-h day-night cycle (lights on 12:00 hours). All experiments were carried out according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (publication no. 85-23, revised 1985) Diazoxide was dissolved in 100 % DMSO as vehicle and diluted with sterile saline to a concentration of 1 mg/ml (0.2 % DMSO) for administration to rats. All other reagents were provided by standard commercial institutes.
Surgery and drug administration
The rats were randomly allocated to five groups (groups A-E), with 15 rats in each group. Rats of groups C-E were pretreated with Ipt (1.5 or 3.0 mg/ kg.d, orally) or diazoxide (3.0 mg/kg.d, orally) for 3 d, simultaneously rats of groups A and B were pretreated with sterile saline containing 0.2 % DMSO. After 3 d, rats of groups B-E were intrastriatally injected with MPP + . Rats of group A (control rats) were intrastriatally injected with saline. Groups C-E were administered Ipt or diazoxide and groups A and B were administered vehicle in the following 7 d. Rats were anaesthetized using 2 % sodium pentobarbital (40 mg/kg i.p.) and placed in a stereotaxic apparatus (Stoelting Instruments, Wood Dale, IL, USA). Unilateral injection of MPP + (26.73 mg/1.8 ml, 90 nmol) was performed in the right striatum (coordinates from bregma : AP +0.9 mm, ML x3.0 mm, DV x5.0 mm) by means of a Hamilton syringe (0.46 mm diameter) at a rate of 1 ml/min, the needle was left in place for 10 min. Sham-lesioned rats were infused with 1.8 ml saline into the right striatum and served as controls.
Behavioural test
The rotarod test, developed for rats by Rozas (Rozas et al., 1998) , is well suited to distinguish persistent motor deficits from temporary inactivity. The rats were kept in the rotarod apparatus at a constant speed of 5 rpm for 3 d before the surgical procedure. Those that were able to remain on the rotating rod for 300 s were selected for the test. The rats were placed on the rod and sequentially tested at 5, 10, 15, 20, 25 and 30 rpm, for maximum of 300 s at each speed. Animals were given at least 5 min rest between successive speeds to alleviate stress and fatigue. Time-on-the-rod at each speed [i.e. the maximum time (up to 300 s) that each animal was able to stay on the revolving rod] was plotted against each corresponding speed of rotation. The overall rod performance (ORP) score for each animal was calculated as the area under the curve in the plot of time-on-the-rod against rotation speed. All tests commenced at about the same time.
Immunochemistry and stereology
The remaining animals were anaesthetized by chloral hydrate and perfused first with 0.9 % saline and then with cold 4 % paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brains were dissected out and maintained in 4 % paraformaldehyde overnight. Brains were cryopreserved in 30 % sucrose in phosphatebuffered saline (PBS) and stored at 70 xC until required. Free-floating sections encompassing the entire midbrain were prepared using a cryostat. Sections were processed for tyrosine hydroxylase (TH) and glial fibrillary acidic protein (GFAP) immunohistochemistry as follows. Following incubation for 1 h in 10 % bovine serum albumin (BSA) with 0.3 % Triton X-100 in 0.01 M PBS, tissue sections (30 mm) were incubated with primary antibodies overnight at 4 xC. Primary antibodies used in this study were as follows : mouse anti-TH (1 : 4000 ; Sigma), mouse anti-GFAP (1 : 300 ; Sigma) and mouse anti-ED1 (1 : 100 ; Serotec, Raleigh, NC, USA). Immunostaining was visualized by using 3,3k-diaminobenzidine and sections were then counterstained with haematoxylin. All counts were performed by researchers blind to the experimental status of the animals. The total number of TH-immunoreactive (IR) neurons and GFAP-IR astrocytes in substantia nigra pars compacta (SNpc) were counted from six rats per group by using the optical fractionator method (West, 1993) , an unbiased method of cell counting that is not affected by either the volume of reference (i.e. SNpc) or the size of the counted elements (i.e. neurons) (Stereo Investigator software, Microbrightfield, Colchester, VT, USA). In agreement with this method, TH-IR neurons and GFAP-IR astrocytes were counted in the intact and lesioned SNpc of every fourth section (30 mm) throughout the entire extent of the SNpc. Each midbrain section was viewed at low power (r10 objective), and the SNpc was outlined according to the established anatomical landmarks (the rat brain atlas of Paxinos and Watson, 1997) . Then at a random start, the number of TH-IR neurons and GFAP-IR astrocytes were counted at high power (r100 oil). To avoid double counting of cells with unusual shapes, TH-IR neurons and GFAP-IR astrocytes were counted only when their nuclei were optimally visualized, which occurred only in one focal plane. After all of the TH-IR neurons and GFAP-IR astrocytes were counted, the total numbers of TH-IR neurons and GFAP-IR astrocytes in the SNpc were calculated by using the formula described by West (1993) . Sampling grid dimensions were 120r120r5 mm (x, y, z axes).
Astrocyte cell culture
Rat primary astrocyte cultures were prepared from the midbrain of 2-d-old Sprague-Dawley rats and plated on poly D-lysine pre-coated cell-culture flasks containing DMEM (10 % fetal calf serum, 100 U/ml penicillin and 100 mg/ml streptomycin). Cultures were maintained at 37 xC in a humidified atmosphere of 5 % CO 2 /95 % air. Under these conditions, confluent cultures were achieved after 10 d in vitro and the cells were >96 % positive for GFAP as assessed by immunocytochemical staining.
GFAP immunocytochemistry
Astrocytes were fixed in 4 % paraformaldehyde in 0.1 M PBS for 15 min at room temperature, permeabilized with 0.1 % Triton X-100, and rinsed three times, each for 10 min with PBS containing 0.2 % BSA. The primary antibodies, mouse anti-GFAP antibodies (1 : 300 ; Sigma), were applied to the samples and kept at 4 xC overnight. The following day the cells were rinsed three times with PBS. Secondary antibodies were applied to samples and kept at 37 xC for 1 h. Samples were then rinsed three times with PBS and immunostaning was visualized by using 3,3k-diaminobenzidine.
TNF-a assay
The amount of TNF-a in the peripheral blood and culture medium was determined 24 h after treatment Iptakalim inhibits astrocyte activation 319 by guest on October 7, 2016 http://ijnp.oxfordjournals.org/ Downloaded from with a rat TNF-a enzyme-linked immunosorbent assay (ELISA) kit (BioSource International, Camarillo, CA, USA).
Western blotting
Cells were washed twice with ice-cold PBS and homogenized in 200 ml lysis buffer. After incubation for 20 min on ice, cell lysates were centrifuged (10000 g for 10 min at 4 xC) and protein concentration in the extracts was determined by the Bradford assay (Kruger, 1994) . Proteins in cell extracts were denatured with SDS sample buffer and separated by 10 % SDS-PAGE. Proteins were transferred to nitrocellulose membranes using a Bio-Rad miniprotein-III wet transfer unit. The membranes were incubated with 5 % BSA dissolved in TBST (pH 7.5 ; 10 mM Tris-HCl, 150 mM NaCl, and 0.1 % Tween-20) at room temperature for 1 h, washed three times and incubated with different antibodies (p38 and phospho-p38 at 1 : 1000, Cell Signaling Technology Inc., Beverly, MA, USA). The membranes were washed three times with TBST buffer and incubated with the secondary antibody (1 : 2000) for 1 h followed by four washings. Signal detection was performed with an enhanced chemiluminescence kit (Cell Signaling Technology).
Statistical analysis
All values were expressed as mean¡standard error of the mean (S.E.M.). The significance of the difference between control and samples treated with various drugs was determined by one-way ANOVA followed by the post-hoc least significant difference test. Differences were considered significant at p<0.05.
Results
Ipt alleviates MPP
+ -induced behavioural symptoms in rotarod motor performance
In order to assess the effect of Ipt on motor function in rats, the rotarod test was examined on day 7 following vehicle or MPP + treatment. It was shown that vehicletreated animals learned the task quickly and, after a short training period, were able to remain on the rod at different speeds (5-20 rpm). They stepped voluntarily from the hand of the experimenter onto the rotarod, except at very high rotation speeds. The ORP scores of control animals was about 6694 s. However, unilateral Ipt suppresses the increase of TNF-a production from reactive astrocytes and the activation of p38 MAPK induced by MPP + Rat primary-cultured astrocytes were used for in-vitro study to further investigate the inhibitory effect of Ipt on astrocyte activation. In the present study, GFAP immunocytochemistry was performed to analyse astrocyte activation in the primary culture. As shown in Figure 4 , the administration of MPP + could induce notable astrocyte activation, indicated by larger cell body and hypertrophic processes. Either Ipt or diazoxide pretreatment significantly suppresses astrocyte activation, indicated by thin, clearly distinguishable processes, which was abolished by 5-hydroxydecanoate (5-HD).
As shown in Figure 5a , incubation with MPP (Figure 6a ). The result suggests that the p38 MAPK signalling pathway was activated in response to MPP + treatment in astrocytes. Next, we detected whether Ipt could regulate MPP + -induced p38 MAPK phosphorylation at the 30-min time-point. As shown in Figure 6b , pretreatment with 10 mM Ipt or 100 mM diazoxide could suppress MPP + -induced increase of phospho-p38 level by >65 %, and the suppressive effects of Ipt and diazoxide were reversed by 5-HD (250 mM). These data further suggest that Ipt can inhibit MPP + -induced pro-inflammatory factor production from reactive astrocytes by regulating the p38 MAPK signalling pathway.
Discussion
The present study shows that systematic administration with Ipt significantly alleviated MPP + -induced behavioural symptoms in motor coordination, the loss of dopaminergic neurons, and the activation of astrocytes and microglia in the SNpc. Ipt also decreased MPP + -induced TNF-a release and p38 MAPK activation in reactive astrocytes, which was abolished by the selective mito-K ATP channel blocker 5-HD. Astrocyte activation is a prominent occurrence following injury to the CNS (Marchetti and Abbracchio, 2005 ; Teismann et al., 2003) . Enhancement in the immunoreactivity of GFAP is found in the striatum and substantia nigra of PD patients and mice treated with MPTP (Mirza et al., 2000 ; Smeyne et al., 2005) . In the MPTP mouse model, astrocyte activation is concomitant with the death of neurons (Przedborski et al., 2000) . Therefore, it is possible that reactive astrocytes plays a key role in regions damaged by MPTP (Watanabe et al., 2005) . Coincidentally, a body of evidence has shown that reactive astrocytes can confer neuronal destruction by synthesizing and releasing pro-inflammatory cytokines following neuronal injury (Ikeda and Murase, 2004 ; Minghetti, 2005) . Cytotoxic factors produced by reactive astrocytes can damage local neural cells, and reactive astrocytes can actively contribute to secondary degeneration after CNS insults or in response to inflammatory signalling cues (Hirsch, 2000 ; Liu et al., 2002) . Therefore, inhibition of astrocyte activation and subsequent release of proinflammatory factors may offer prospective clinical therapeutic benefit for PD.
Ipt, a novel K ATP channel opener, exhibited significant neuroprotective effect in preventing rotenoneinduced behavioural alterations and dopamine deletion, as well as protecting SH-SY5Y cells against death Yang et al., 2004 Yang et al., , 2005 Yang et al., , 2006b ). We also found that Ipt could alleviate rotenoneinduced degeneration of dopaminergic neurons by inhibiting microglia-mediated neuroinflammation . Liberatore et al. (1999) have reported that changes in MAC-1 expression were evident after 12 h, (Zhang et al., 2007) , we propose that Ipt may protect astrocytes by regulating MAPK signalling transduction. The function of early glial response following brain injury may be part of the repair and protective response, but the presence of site-specific microglia and astrocyte activation in human neurodegenerative diseases such as PD (Teismann et al., 2003 ; Forno et al., 1992) raises the question of whether this response could contribute to the developing injury. Indeed, blocking of microglia activation decreases TH-IR neuronal loss triggered by MPTP or lipopolysaccharides (Lu et al., 2000 ; Wu et al., 2002) . Similarly, suppression of astrocyte response with arundic acid [(R)-(-)-2-propyloctanoic acid, ONO-2506] reduced the number of TUNEL-positive apoptotic cells in the perinfarct area, prevented delayed infarct expansion and ameliorated neurological deficits after permanent middle cerebral artery occlusion, indicating a deleterious effect of reactive astrocytes (Tateishi et al., 2002) . The present findings indicate that inhibition of astrocyte activation by Ipt might be involved in its protective effects on MPP + -induced degeneration of dopaminergic neurons in rats.
The present study also showed that the selective mito-K ATP channel opener diazoxide had a similar protective effect to that of Ipt. Moreover, the inhibitory effect of Ipt or diazoxide on inflammatory factor release from activated astrocytes was abolished by the selective mito-K ATP channel blocker 5-HD. These findings suggest that Ipt may regulate TNF-a released from reactive astrocytes via opening mito-K ATP channels in astrocytes and subsequently exert neuroprotective effects. Accumulating evidence has shown that the amount of mito-K ATP channels located in brain cells is at least 6-fold higher than that in heart cells (Bajgar et al., 2001 ; Lacza et al., 2003) , indicating an essential role of mito-K ATP channel in the physiology and pathology of the CNS. Previous studies have shown that K ATP channel openers, especial mito-K ATP channel openers, can provide protective effects for neurons, and neuroblast against ischaemia, trauma and toxic reagents such as rotenone and MPP Wang et al., 2004 ; Yang et al., 2006b) . There are only a few studies that reveal the role of K ATP channels in the regulation of astrocyte functions. Rajapakse et al. (2003) reported that opening K ATP channels could prevent astrocyte death induced by oxygen glucose deprivation and H 2 O 2 . Our previous study found that opening K ATP channels could increase the glutamate uptake and subsequently decrease the extracellular accumulation of glutamate induced by MPP + in astrocytes .
Nakagawa
Thus, opening K ATP channels of astrocytes may exhibit neuronal protection by regulating astrocyte function. Diazoxide, a selective mito-K ATP channel opener, was originally developed as an antihypertensive agent, but was found to induce hyperglycaemia by reducing insulin secretion. The clinical use of diazoxide has been hampered by its lack of potency and selectivity giving rise to side-effects (Hansen, 2006) . It has been demonstrated that diazoxide conferred neuroprotective effect on various in-vivo cerebral ischaemia models and neuronal cell cultures exposed to oxygen-glucose deprivation (Domoki et al., 2004 ; Kis et al., 2003 ; Teshima et al., 2003) . In comparison, Ipt possesses several advantages, such as free penetration through the blood-brain barrier and low toxic side-effects during systemic administration, Ipt also exerts neuroprotective effects in doses not affecting blood pressure . Therefore, Ipt is a promising compound that may protect neurons against neurodegenerative diseases. Further, Ipt may be the lead compound for medicinal chemistry refinements to synthesize drugs that have selective effects on glial K ATP channels.
In conclusion, the present study demonstrates that inhibition of astrocyte activation and subsequent release of pro-inflammatory factors by opening mito-K ATP channels in astrocytes may be a prospective strategy for neuroprotection. As a novel and bloodbrain barrier permeable K ATP channel opener, Ipt can inhibit MPP + -induced astrocyte activation thereby protecting against the degeneration of dopaminergic neurons.
